These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 8566856)

  • 21. Identification of somatostatin receptor subtypes and an implication for the efficacy of somatostatin analogue SMS 201-995 in treatment of human endocrine tumors.
    Kubota A; Yamada Y; Kagimoto S; Shimatsu A; Imamura M; Tsuda K; Imura H; Seino S; Seino Y
    J Clin Invest; 1994 Mar; 93(3):1321-5. PubMed ID: 8132773
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Somatostatin receptor scintigraphy in liver metastasis detection from gastroenteropancreatic neuroendocrine tumors.
    Schillaci O; Spanu A; Scopinaro F; Falchi A; Danieli R; Marongiu P; Pisu N; Madeddu G; Delle Fave G; Madeddu G
    J Nucl Med; 2003 Mar; 44(3):359-68. PubMed ID: 12621001
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nuclear medicine techniques for the imaging and treatment of neuroendocrine tumours.
    Teunissen JJ; Kwekkeboom DJ; Valkema R; Krenning EP
    Endocr Relat Cancer; 2011 Oct; 18 Suppl 1():S27-51. PubMed ID: 22005114
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gastroenteropancreatic tumor imaging with somatostatin receptor scintigraphy.
    Wiedenmann B; Bäder HM; Scherubl H; Fett U; Zimmer T; Hamm B; Koppenhagen K; Riecken EO
    Semin Oncol; 1994 Oct; 21(5 Suppl 13):29-32. PubMed ID: 7992077
    [No Abstract]   [Full Text] [Related]  

  • 25. Use of somatostatin analogue scintigraphy in the localization of recurrent medullary thyroid carcinoma.
    Bernà L; Chico A; Matías-Guiu X; Mato E; Catafau A; Alonso C; Mora J; Mauricio D; Rodríguez-Espinosa J; Marí C; Flotats A; Martín JC; Estorch M; Carrió I
    Eur J Nucl Med; 1998 Nov; 25(11):1482-8. PubMed ID: 9799343
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical impact of somatostatin receptor scintigraphy in the management of patients with neuroendocrine gastroenteropancreatic tumors.
    Lebtahi R; Cadiot G; Sarda L; Daou D; Faraggi M; Petegnief Y; Mignon M; le Guludec D
    J Nucl Med; 1997 Jun; 38(6):853-8. PubMed ID: 9189129
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A new radiolabelled somatostatin analogue [111In-DTPA-D-Phe1]RC-160: preparation, biological activity, receptor scintigraphy in rats and comparison with [111In-DTPA-D-Phe1]octreotide.
    Breeman WA; Hofland LJ; van der Pluijm M; van Koetsveld PM; de Jong M; Setyono-Han B; Bakker WH; Kwekkeboom DJ; Visser TJ; Lamberts SW
    Eur J Nucl Med; 1994 Apr; 21(4):328-35. PubMed ID: 7911760
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expression of somatostatin receptor (SSTR) subtypes in pituitary adenomas: quantitative analysis of SSTR2 mRNA by reverse transcription-polymerase chain reaction.
    Murabe H; Shimatsu A; Ihara C; Mizuta H; Nakamura Y; Nagata I; Kikuchi H; Nakao K
    J Neuroendocrinol; 1996 Aug; 8(8):605-10. PubMed ID: 8866248
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Localization of metastatic gastroenteropancreatic tumours by somatostatin receptor scintigraphy with [111In-DTPA-D-Phe1]-octreotide.
    Hammond PJ; Arka A; Peters AM; Bloom SR; Gilbey SG
    Q J Med; 1994 Feb; 87(2):83-8. PubMed ID: 8153292
    [TBL] [Abstract][Full Text] [Related]  

  • 30. 111In-labelled octreotide binding by the somatostatin receptor subtype 2 in neuroendocrine tumours.
    Hashemi SH; Benjegård SA; Ahlman H; Wängberg B; Forssell-Aronsson E; Billig H; Nilsson O
    Br J Surg; 2003 May; 90(5):549-54. PubMed ID: 12734860
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Indium-111-octreotide scintigraphy, intraoperative gamma-detector localisation and somatostatin receptor expression in primary human breast cancer.
    Skånberg J; Ahlman H; Benjegård SA; Fjälling M; Forssell-Aronsson EB; Hashemi SH; Nilsson O; Suurkula M; Jansson S
    Breast Cancer Res Treat; 2002 Jul; 74(2):101-11. PubMed ID: 12186370
    [TBL] [Abstract][Full Text] [Related]  

  • 32. 111In-labelled somatostatin analogues in a rat tumour model: somatostatin receptor status and effects of peptide receptor radionuclide therapy.
    Capello A; Krenning E; Bernard B; Reubi JC; Breeman W; de Jong M
    Eur J Nucl Med Mol Imaging; 2005 Nov; 32(11):1288-95. PubMed ID: 16021448
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Somatostatin receptors and disease: role of receptor subtypes.
    Hofland LJ; Lamberts SW
    Baillieres Clin Endocrinol Metab; 1996 Jan; 10(1):163-76. PubMed ID: 8734455
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Molecular biologic and scintigraphic analyses of somatostatin receptor-negative meningiomas.
    Meewes C; Bohuslavizki KH; Krisch B; Held-Feindt J; Henze E; Clausen M
    J Nucl Med; 2001 Sep; 42(9):1338-45. PubMed ID: 11535722
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Scintigraphy atlas of somatostatin receptors in neuroendocrine tumors of the pancreas and carcinoid tumors].
    Banzo J; Prats E; Razola P; García S; Alonso V; Velilla J; Freile E; Benito JL; García F; Ubieto MA; Tardín L; Abós MD
    Rev Esp Med Nucl; 2005; 24(4):278-92. PubMed ID: 16122413
    [No Abstract]   [Full Text] [Related]  

  • 36. Somatostatin receptor scintigraphy in gastrinomas.
    Jensen RT; Gibril F
    Ital J Gastroenterol Hepatol; 1999 Oct; 31 Suppl 2():S179-85. PubMed ID: 10604126
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Distribution and functional significance of somatostatin receptors in malignant melanoma.
    Lum SS; Fletcher WS; O'Dorisio MS; Nance RW; Pommier RF; Caprara M
    World J Surg; 2001 Apr; 25(4):407-12. PubMed ID: 11344389
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Is There an Additional Value of Using Somatostatin Receptor Subtype 2a Immunohistochemistry Compared to Somatostatin Receptor Scintigraphy Uptake in Predicting Gastroenteropancreatic Neuroendocrine Tumor Response?
    van Adrichem RC; Kamp K; van Deurzen CH; Biermann K; Feelders RA; Franssen GJ; Kwekkeboom DJ; Hofland LJ; de Herder WW
    Neuroendocrinology; 2016; 103(5):560-6. PubMed ID: 26536001
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Receptor scintigraphy with 111In-pentetreotide for endocrine gastroenteropancreatic tumors.
    Joseph K; Stapp J; Reinecke J; Skamel HJ; Höffken H; Neuhaus C; Lenze H; Trautmann ME; Arnold R
    Horm Metab Res Suppl; 1993; 27():28-35. PubMed ID: 8330869
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Definition of the role of somatostatin receptor scintigraphy in gastrointestinal neuroendocrine tumor localization.
    Jensen RT; Gibril F; Termanini B
    Yale J Biol Med; 1997; 70(5-6):481-500. PubMed ID: 9825476
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.